Skip to main content

Table 2 Study measures and assessment times

From: Efficacy of a Transdiagnostic internet-based treatment for emotional disorders with a specific component to address positive affect: Study protocol for a randomized controlled trial

Measure

Aim

Time of assessment

MINI Neuropsychiatric Interview

Diagnosis

BL, Post-T and FU

PANAS

Positive and negative affect

Post-T and Post-module

BDI-II

Severity of depression

BL, Post-T and FU

BAI

Severity of anxiety

BL, Post-T and FU

OCI-R

Severity of OCD symptoms

BL, Post-T and FU

PDSS-SR

Severity of PD and agoraphobia symptoms

BL, Post-T and FU

PSWQ

Severity of GAD symptoms

BL, Post-T and FU

SIAS

Severity of SAD symptoms

BL, Post-T and FU

NEO FFI

Neuroticism and Extraversion

BL, Post-T and FU

EQ-5D

Health-related quality of life

BL, Post-T and FU

OASIS

Severity of anxiety

Post-module

ODSIS

Severity of depression

Post-module

Suicide item

Suicidal ideation

BL, Post-module, Post-T and FU

Expectation of Treatment Scale

Expectation of treatment

BL

Opinion of Treatment Scale

Opinion of treatment

Post-T

  1. BL, Baseline; Post-T, post-treatment; FU, follow-ups, 3 and 12-month follow-ups; PANAS, Positive and Negative Affect Scale; BDI-II, Beck Depression Inventory-II; BAI, Beck Anxiety Inventory; OCI-R, Obsessive-Compulsive Inventory-Revised; PDSS-SR, Self-Reported Panic Disorder Severity Scale; PSWQ, Penn State Worry Questionnaire; SIAS, Social Interaction Anxiety Scale; NEO FFI, NEO-Five Factor Inventory; EQ-5D, EuroQoL-5D questionnaire; OASIS, Overall Anxiety Severity and Impairment Scale; ODSIS, Overall Depression Severity and Impairment Scale